This is a diagnostic blood test used to identify a group of autoantibodies directed against specific nuclear antigens. These antibodies are commonly associated with autoimmune diseases.
The panel typically includes antibodies such as anti-SSA (Ro), anti-SSB (La), anti-Sm, anti-RNP, anti-Scl-70, and anti-Jo-1.
The purpose of the test is to:
The ENA Panel (Extractable Nuclear Antigen Panel) is a group of blood tests that detects specific autoantibodies directed against nuclear proteins. These antibodies can provide more specific information about certain systemic autoimmune and connective tissue diseases.
The panel may include antibodies such as anti-Ro/SSA, anti-La/SSB, anti-Sm, anti-RNP, anti-Scl-70, and anti-Jo-1, although the exact antibodies included can vary depending on the laboratory's panel.
ENA testing is often performed after an ANA (Antinuclear Antibody) test is positive or when symptoms strongly suggest an autoimmune disorder. Results are interpreted along with symptoms, physical examination, ANA findings, and other laboratory investigations. A positive ENA result alone does not confirm a specific autoimmune disease.
1. What does the ENA Panel detect?
The ENA Panel detects specific autoantibodies against extractable nuclear antigens. These antibodies can help identify patterns associated with different autoimmune connective tissue diseases.
2. Is the ENA Panel the same as an ANA test?
No. ANA is a broader screening test for antinuclear antibodies, while the ENA Panel identifies more specific autoantibodies. ENA testing is often used for further evaluation when autoimmune disease is suspected.
3. Does a positive ENA Panel confirm an autoimmune disease?
Not by itself. A positive result may support the evaluation of an autoimmune condition, but it must be interpreted together with symptoms, medical history, ANA results, examination findings, and other tests.